Enzyme (MLN) is buzzing after surpassing $200M in assets under management. New partnerships with Compound DAO and Polygon, plus anticipation for the Mainnet 2.0 upgrade, are fueling community excitement. However, concerns about low liquidity persist.
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content.See T&Cs.